Figure 1From: Clinical outcomes in typhoid fever: adverse impact of infection with nalidixic acid-resistant Salmonella typhi Histogram depicting the distribution of minimum inhibitory concentration (MIC) of ciprofloxacin of 60 Salmonella typhi isolates and the proportion of nalidixic acid-resistant (NARST) as well as nalidixic acid-susceptible (NASST) isolates in each columnBack to article page